This inventor holds 3 USPTO granted patents. Top assignee: Boehringer Ingelheim Gmbh. Active years: 1982-1986.
Company Filing History:
Years Active: 1982-1986
Title: Heribert Harwalik: Innovator in Pharmaceutical Technologies
Introduction
Heribert Harwalik is a notable inventor based in Ingelheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 3 patents to his name, Harwalik's work focuses on enhancing the efficacy and delivery of pharmaceutical compounds.
Latest Patents
Harwalik's latest patents include groundbreaking inventions that improve the formulation of pharmaceutical products. One of his notable inventions is a retard form of pharmaceuticals with insoluble porous diffusion coatings. This invention relates to a pharmaceutical dosage unit composition that consists of a gelatin capsule containing a disintegrating core comprising clonidine, which has a readily water-soluble coating. Additionally, it includes a plurality of non-disintegrating cores comprising clonidine, with a coating made up of a specific ratio of water-insoluble film former and water-soluble polymer. Another significant patent is a pharmaceutical dosage unit retard form that features a constant, pH-independent release rate of the active ingredient. This formulation consists of a core with an active ingredient and a semi-permeable diffusion coating, which is designed to enhance the release profile of the drug.
Career Highlights
Heribert Harwalik is currently employed at Boehringer Ingelheim GmbH, a leading global pharmaceutical company. His work at Boehringer Ingelheim has allowed him to collaborate with other experts in the field and contribute to the advancement of pharmaceutical technologies.
Collaborations
Throughout his career, Harwalik has worked alongside esteemed colleagues such as Bernhard Freund and Dietrich Arndts. These collaborations have fostered an environment of innovation and have led to the successful development of new pharmaceutical formulations.
Conclusion
Heribert Harwalik's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his role as a key inventor in the field. His work continues to influence the development of effective pharmaceutical products that improve patient outcomes.